Talia Golan
Tel Aviv University(IL)Sheba Medical Center(IL)
Publications by Year
Research Areas
Pancreatic and Hepatic Oncology Research, Cancer Genomics and Diagnostics, PARP inhibition in cancer therapy, Diabetes and associated disorders, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → The human tumor microbiome is composed of tumor type–specific intracellular bacteria(2020)2,260 cited
- → Maintenance Olaparib for Germline BRCA -Mutated Metastatic Pancreatic Cancer(2019)2,145 cited
- → Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer(2018)1,796 cited
- → Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine(2017)1,694 cited
- → Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial(2016)1,123 cited
- → Identification of tissue-specific cell death using methylation patterns of circulating DNA(2016)614 cited
- → BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial(2020)514 cited
- → Hallmarks of transcriptional intratumour heterogeneity across a thousand tumours(2023)474 cited
- → Pancreatic cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up(2023)440 cited
- → Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers(2014)433 cited